Whether early treatment of SIV infection can delay immune destruction allowing time for developing more effective protection is pertinent now that more effective treatment is available. We studied infected monkeys surviving long-term after treatment with (R)-9-(2-phosphonyl-methoxypropyl) adenine (PMPA). Two of 5 monkeys treated for 28 days beginning 24 hours after SIV inoculation survived over 1,069 days. Infection establishment was prevented since virus could not be isolated; provirus could not be detected; antibodies did not develop; and lymphocyte subsets remained stable. Five other monkeys received long-term PMPA treatment beginning 14 days after SIV infection. A strong antiviral effect occurred in 3/5 monkeys. After only 7 days of treatment plasma virus decreased an average of 3.4 logs (99.8%). A much weaker antiviral effect was observed in 2 other monkeys which after 7 days treatment had decreases of only 1.2 logs (93.7%). Treatment was stopped in 3 of these monkeys af ter 448 to 469 days. In 1 monkey which had high plasma viral RNA levels throughout treatment, the RNA level only increased 0.6 log after cessation. A sharp decrease in CD4+ cells after treatment stopped suggested that treatment had exerted a protective effect even though the plasma viral RNA had not decreased to low levels. In another monkey the plasma SIV RNA had been held below quantifiable levels by PMPA; stopping treatment resulted in marked increases in plasma viral RNA, proviral DNA, and antigenemia accompanied by rapidly decreasing CD4+ cells. The third monkey showed only a slight increase in plasma viral RNA after treatment cessation that did not progress, and CD4+ cells remained stable. The latter 2 monkeys remain alive 586 days after stopping treatments. Their long survival suggests that early treatment may allow development of protective mechanisms which may prolong survival even after treatments cease. FUNDING NIH-N01-AI-15119 PUBLICATIONS None

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Primate Research Center Grants (P51)
Project #
5P51RR000164-41
Application #
6591734
Study Section
Project Start
2002-05-01
Project End
2003-04-30
Budget Start
Budget End
Support Year
41
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Tulane University
Department
Type
DUNS #
City
New Orleans
State
LA
Country
United States
Zip Code
70118
Mahalingam, Ravi; Kaufer, Benedikt B; Ouwendijk, Werner J D et al. (2018) Attenuation of Simian Varicella Virus Infection by Enhanced Green Fluorescent Protein in Rhesus Macaques. J Virol 92:
Kumar, Vinay; Mansfield, Joshua; Fan, Rong et al. (2018) miR-130a and miR-212 Disrupt the Intestinal Epithelial Barrier through Modulation of PPAR? and Occludin Expression in Chronic Simian Immunodeficiency Virus-Infected Rhesus Macaques. J Immunol 200:2677-2689
Parthasarathy, Geetha; Philipp, Mario T (2018) Intracellular TLR7 is activated in human oligodendrocytes in response to Borrelia burgdorferi exposure. Neurosci Lett 671:38-42
McNamara, Ryan P; Costantini, Lindsey M; Myers, T Alix et al. (2018) Nef Secretion into Extracellular Vesicles or Exosomes Is Conserved across Human and Simian Immunodeficiency Viruses. MBio 9:
Calenda, Giulia; Villegas, Guillermo; Barnable, Patrick et al. (2017) MZC Gel Inhibits SHIV-RT and HSV-2 in Macaque Vaginal Mucosa and SHIV-RT in Rectal Mucosa. J Acquir Immune Defic Syndr 74:e67-e74
Datta, Dibyadyuti; Bansal, Geetha P; Grasperge, Brooke et al. (2017) Comparative functional potency of DNA vaccines encoding Plasmodium falciparum transmission blocking target antigens Pfs48/45 and Pfs25 administered alone or in combination by in vivo electroporation in rhesus macaques. Vaccine 35:7049-7056
Yi, Fei; Guo, Jia; Dabbagh, Deemah et al. (2017) Discovery of Novel Small-Molecule Inhibitors of LIM Domain Kinase for Inhibiting HIV-1. J Virol 91:
Jorgensen, Matthew J; Lambert, Kelsey R; Breaux, Sarah D et al. (2017) Pair housing of Vervets/African Green Monkeys for biomedical research. Am J Primatol 79:1-10
Ramesh, Geeta; Martinez, Alejandra N; Martin, Dale S et al. (2017) Effects of dexamethasone and meloxicam on Borrelia burgdorferi-induced inflammation in glial and neuronal cells of the central nervous system. J Neuroinflammation 14:28
Parthasarathy, Geetha; Philipp, Mario T (2017) Receptor tyrosine kinases play a significant role in human oligodendrocyte inflammation and cell death associated with the Lyme disease bacterium Borrelia burgdorferi. J Neuroinflammation 14:110

Showing the most recent 10 out of 352 publications